Výsledky vyhledávání - "Douglas W Hackenyos"

Qualitative and quantitative variations in liver function thresholds among clinical trials in cancer: a need for harmonization

Autor: Fei Song, Paul Mathew, Douglas W Hackenyos, Edwin Wang, Jessica K. Paulus

Publikováno v: Cancer Chemotherapy and Pharmacology. 84:213-216

The liver is critically involved in drug metabolism pathways and the potential for hepatic toxicity is significant with specific cancer therapeutics. Variations in the definition of liver function thresholds that may generate heterogeneity of toxicit

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::81b8ebe35122ed817fd0e1a99e9e4ace
https://doi.org/10.1007/s00280-019-03821-6

Zobrazit plný text záznamu

Assessment of patients' understanding of and adherence to oral anticancer medication (OAM): Results of a cross-sectional institutional pilot study

Autor: Raisa Masood, Nicole Savidge, Angie Mae Rodday, Ruth Ann Weidner, Mingqian Lin, Susan K. Parsons, Douglas W Hackenyos

Publikováno v: J Oncol Pharm Pract

Background Although oral anticancer medications (OAM) provide opportunity for treatment at home, challenges include prescription filling, monitoring side effects, safe handling, and adherence. We assessed understanding of and adherence to OAM in vuln

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::06e3834a2b31070d4ffa1b361d8880a2
https://pubmed.ncbi.nlm.nih.gov/33019872

Zobrazit plný text záznamu

Enhancing patients' understanding of and adherence to oral anticancer medication: Results of a longitudinal pilot intervention

Autor: Angie Mae Rodday, Mingqian Lin, Susan K. Parsons, Ruth Ann Weidner, Nicole Savidge, Rachel Murphy-Banks, Douglas W Hackenyos, Tara Fleckner

Publikováno v: J Oncol Pharm Pract

Background Oral anticancer medications (OAM) make administration more convenient for patients, but shifts the responsibility of care from clinical providers to the patients themselves. Following an institutional pilot study showing inadequate underst

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6db412ebf3b8c0cd76eb8e32f05c7176
https://pubmed.ncbi.nlm.nih.gov/32996363

Zobrazit plný text záznamu

Imprecise Kidney Function Thresholds in Cancer Clinical Trials and the Potential for Harm

Autor: Jessica K. Paulus, Lesley A. Inker, Andrew S. Levey, Paul Mathew, Douglas W Hackenyos, Edwin Wang

Publikováno v: JNCI Cancer Spectrum

Current guidance for evaluation of kidney function and drug dosing emphasize using measured or estimated glomerular filtration rate (GFR) rather than measured or estimated creatinine clearance or serum creatinine (Scr) alone. We assessed the definiti

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7778a2822f95541d56063917c6ebab9b
https://doi.org/10.1093/jncics/pky060

Zobrazit plný text záznamu

Pilot study to assess a pharmacist- and medication navigator-led intervention of oral anticancer medication (OAM) adherence

Autor: Rachel Murphy-Banks, Ruth Ann Weidner, Nicole Savidge, Angie Mae Rodday, Douglas W Hackenyos, Susan K. Parsons, Mingqian Lin

Publikováno v: Journal of Clinical Oncology. 37:58-58

58 Background: While advances in OAM make treatment more convenient for patients, OAM must be taken and handled correctly. Studies show gaps in patients’ knowledge of taking/handling OAM, suboptimal adherence, and worse outcomes. A prior study at o

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::3e568c5eaf42fda7ad511c451e4f2505
https://doi.org/10.1200/jco.2019.37.27_suppl.58

Zobrazit plný text záznamu

Patients’ understanding and adherence to oral anti-cancer medication (OAM): Results of an institutional pilot study

Autor: Rachel Murphy-Banks, Ruth Ann Weidner, Nicole Savidge, Feng Qing Wang, Angie Mae Rodday, Raisa Masood, John K. Erban, Rachel J. Buchsbaum, Mingqian Lin, Douglas W Hackenyos, Susan K. Parsons, Daqin Mao

Publikováno v: Journal of Clinical Oncology. 37:e18280-e18280

e18280 Background: Advancements in biopharmaceuticals have led to increasing availability and use of OAM. While oral medications allow patients (pts) to receive treatment at home, OAM use introduces new challenges related to prescription filling, mon

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::fa630948d2c74516f0b0131dbdd0b9e9
https://doi.org/10.1200/jco.2019.37.15_suppl.e18280

Zobrazit plný text záznamu

Ethnic differences in pegfligrastim onpro kit (on-body injector) use among cancer patients

Autor: Komal Wasif, Wasif M. Saif, Douglas W Hackenyos, Valerie Relias, Patricia Healey, Melissa H Smith

Publikováno v: Journal of Clinical Oncology. 36:e18668-e18668

e18668Background: Most studies of racial and ethnic disparities in health care have focused on technical aspects of care, such as diagnostics or therapies while less is known about ethnic differenc...

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::ce51d56ea40a0e9ae7f2ee211243402c
https://doi.org/10.1200/jco.2018.36.15_suppl.e18668

Zobrazit plný text záznamu

Utilizing patient navigators to enhance oral chemotherapy education and safety for at-risk patients

Autor: Mingqian Lin, Daqin Mao, Feng Qing Wang, John K. Erban, Susan K. Parsons, Douglas W Hackenyos

Publikováno v: Journal of Clinical Oncology. 35:43-43

43 Background: Oral anticancer drugs are increasingly being used as standard therapy. At Tufts Medical Center Cancer Center, 10% of patients on active cancer treatment are receiving oral chemotherapy. To address barriers to medication education and t

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::ef50465dacc8c975d5b8bdf6a0379966
https://doi.org/10.1200/jco.2017.35.8_suppl.43

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání